冷冻保存同种异体血管用于外周动脉感染的重建经验
中位随访34个月,CPA相关并发症包括狭窄/血栓形成(18%)、再感染(8%)、破裂(3%)和吻合口裂开(3%),1年和3年无CPA相关并发症率分别为74%和61%。结论认为CPA是感染/污染术野中外周动脉重建的可行导管选择,但需密切监测和长期随访。
要点
- CPA可用于感染或污染术野的外周动脉重建,3年截肢率低(n=2)。
- CPA相关并发症以狭窄/血栓形成为主(18%),需警惕再感染和破裂。
- 1年和3年生存率均为77%,提示需长期随访监测并发症。
核心结论
- CPA是感染或污染术野外周动脉重建的可行导管选择,截肢无生存率较好但需再干预。
研究设计与样本
- 排除CPA静脉重建、透析通路及非感染非污染术野的旁路手术。
主要发现
- CPA使用指征:感染人工血管(58%)、感染牛心包补片(21%)、感染支架移植物(8%)、自体动脉感染(8%)、污染术野血管损伤(5%)。
- 重建部位:下肢87%、上肢11%、颈动脉3%。
- 中位随访34个月,CPA相关并发症:狭窄/血栓形成18%、再感染8%、破裂3%、吻合口裂开3%。
- 1年和3年无CPA相关并发症率分别为74%和61%;1年和3年生存率均为77%。
- 及时再干预(n=11)使3年总截肢率低(n=2)。
临床怎么用
- 对感染或污染术野的外周动脉重建,CPA可作为替代导管选项。
- 术后需密切监测和长期随访,以及时发现并处理CPA相关并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To assess outcomes of peripheral arterial reconstruction using cryopreserved allograft (CPA) in infected or contaminated operative fields. METHODS: A retrospective review was performed on patients who underwent peripheral arterial reconstruction using CPA in infected/contaminated fields at a quaternary medical center (2000-2025). CPA venous reconstruction, dialysis access, and bypass in noninfected and noncontaminated fields were excluded. Outcomes assessed included overall survival, CPA-related complications (graft reinfection, stenosis/thrombosis, degeneration, dehiscence, and rupture), limb loss, and CPA-related reinterventions. RESULTS: Thirty-five patients (23 male) with median age of 67 years old in whom 38 CPAs were implanted were included. Indications for CPA use were infected prosthetic graft (58%), infected bovine patch (21%), infected stent graft (8%), native arterial infections (8%), and vascular injuries in contaminated fields (5%). Vascular reconstructions involved the lower extremity in 87% of cases, the upper extremity in 11%, and the carotid artery in 3%. At a median follow-up of 34 months, CPA-related complications included stenosis/thrombosis (18%), reinfection (8%), rupture (3%), and anastomotic dehiscence (3%). Freedom from CPA-related complication was 74% at 1 year and 61% at 3 years. Prompt reintervention (n = 11) resulted in an overall low amputation rate at 3 years (n = 2). One-year and 3-year survival rates were both 77%, respectively. CONCLUSION: CPA is a viable conduit option for peripheral arterial reconstruction in infected or contaminated fields. The occurrence of CPA-related complications underscores the need for careful surveillance and longitudinal follow-up. These data support the use of CPA as a viable conduit in complex cases where alternative options are limited, demonstrating favorable amputation-free survival, though with some needs for reintervention.
引用
- Lee MY, Halabi M, Shepard A, et al. Peripheral Arterial Infections: Experience with Cryopreserved Allografts. Ann Vasc Surg. 2026. PMID: 42790698. doi:10.1016/j.avsg.2026.09.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。